Swiss Re Independently Validates 25:1 Return on Investment for Cancer Rehabilitation. Osara Health Delivered 91% of the Program Data.
· Apr 7, 2026
<p>Osara Health discloses its role as the primary cancer support provider in Swiss Re's independent Rehabilitation Watch 2025 report, which confirmed a 25:1 return on investment and the highest return-to-work rate of any condition at 71%. NEW YORK, April 7, 2026 /PRNewswire/ -- Swiss Re's...</p>
This article was originally published at www.prnewswire.com.